Furthermore, co-existing myelin oligodendrocyte glycoprotein antibody (MOG-Ab) in patients diagnosed with anti-NMDAR encephalitis is not rare, and this subpopulation of patients may have different response to treatment according to previous studies (8–10). This evidence concerns the gene MOG and encephalitis.